Supplementary Figure S5. Trastuzumab produced by oncolytic adenovirus in vivo binds to HER2-positive N87 cancer cells from Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer